Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Research and development

Sales and marketing

General and administrative

Restructuring

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Doximity

Doximity, Inc. develops an online healthcare resource and interactive platform. The Company cloud-based platform enables its members to collaborate with their colleagues, securely coordinate patient care, and conducts virtual patient visits. Doximity serves customers in the United States.

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Earnings data Q3 2025

Earnings data Q4 2025

Earnings data Q1 2026

Earnings data Q2 2026

Earnings data Q3 2026

Earnings data Q4 2026

Doximity surpasses Q4 revenue targets, poised for growth and innovation

Doximity's Q4 performance exceeded expectations, with robust revenue growth, strong margins, and strategic investments in new products and talent.
While facing challenges like flat growth in certain segments and pricing adjustments, the company is well-positioned to capitalize on opportunities in network expansion and technology innovation.
With a focus on enhancing user experience, driving engagement, and optimizing revenue streams, Doximity is poised for continued success and value creation for shareholders.
The company's financial health, innovative product offerings, and market positioning indicate a promising outlook for sustained growth and competitive advantage in the healthcare technology sector.

Doximity surpasses Q1 revenue expectations, faces upsell challenges

Doximity's Q1 performance was strong, but challenges in upsells prompted a staff reduction and revised guidance. The company is optimistic about long-term growth, leveraging new products and a self-serve ad platform for future success.

Doximity beats Q2 expectations, eyes growth amidst market uncertainties

Doximity's strong Q2 performance exceeded revenue and EBITDA guidance, driven by record physician engagement and new product success.
While facing market uncertainties and competition challenges, the company sees opportunities in pricing strategies and continued growth.
Investments in high-touch services, Telehealth, and video products are paying off, with a focus on enhancing client offerings.
Integration with IQVIA for real-time ROI analysis positions Doximity for future growth and client value creation.

Doximity beats Q3 revenue, eyes growth through AI products

Doximity's Q3 performance exceeded expectations with strong revenue and margin growth. The company faces challenges with elongated sales cycles but has opportunities for growth through AI products and new modules. Overall, Doximity's competitive position remains strong in the market.

Doximity exceeds Q4 revenue, eyes mid-teens growth post-COVID

Doximity's Q4 earnings call highlighted strong financial performance, customer satisfaction initiatives, and growth opportunities in digital marketing and new business segments. While facing challenges in growth slowdowns and market uncertainties, the company is leveraging strengths in optimized margins, visibility into revenue guidance, and customer commitment to drive future success.

Doximity excels in Q1 2025, driving growth through client value

Doximity's Q1 2025 performance reflects strong revenue growth, operational efficiency, and client value proposition.
The company's focus on innovation, customer engagement, and strategic insights positions it well for sustained growth.
Despite challenges, Doximity's proactive approach to industry dynamics and growth opportunities bodes well for future success.

Doximity excels in Q3 with record revenue and user engagement

Doximity's Q3 performance reflects strong revenue growth, profitability, and user engagement, positioning the company well in the digital healthcare market.
The company's recognition as a top telehealth platform, successful product launches, and AI utilization highlight its competitive strengths.
Challenges include sustaining growth rates, managing costs, and adapting to market dynamics, while opportunities lie in market expansion and innovation.
Overall, Doximity's strategic focus on growth and customer-centric initiatives bodes well for its future success in the evolving healthcare landscape.

Doximity surpasses revenue targets, eyes AI growth and disciplined investments

Doximity delivered strong financial performance in Q4 2025, exceeding revenue guidance and showcasing robust EBITDA margins. The company's emphasis on AI tools, client engagement, and disciplined investment approach positions it well for future growth. With a healthy cash position and a focus on market expansion, Doximity is poised for continued success in the healthcare technology sector.

Doximity excels in Q2, eyes AI growth amid budget uncertainties

Doximity's Q2 performance showcases robust revenue growth, strong network engagement, and successful AI integration, driving an optimistic outlook for the company. While facing budget uncertainties and AI investment challenges, Doximity's focus on client engagement and technological innovation positions it well for future growth. The company's strategic strengths in pharma business, AI solutions, and user adoption underscore its potential for sustained success and market leadership.

Doximity excels in Q3 with strong financials and AI adoption

Doximity's Q3 2026 earnings call highlighted robust financial performance, strong AI product adoption, and a focus on physician-centric AI tools. While facing challenges from policy changes impacting budget decisions, the company remains optimistic about future growth and upsell opportunities. Strategic investments in AI technology, market expansion, and maintaining high EBITDA margins underscore Doximity's commitment to innovation and financial stability.